Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer

GlobeNewswire Inc. | Oct 1, 2026 7:00 AM EDT

Leader in Global Drug Development of T Cell Therapies